News
Public · Published
Create Medic: Sales grew, but 9M profit fell sharply; FY guidance retains a ¥47 dividend
Create Medic reported that sales for the nine months of fiscal 2026 rose 4.1% year over year, while operating profit fell 44.2% and profit attributable to the parent company dropped 54.7%. Its full-year guidance expects modest sales growth, lower profits, and an annual dividend of ¥47.
Published:
Updated:
What happened
Create Medic reported that sales for the nine months of fiscal 2026 rose 4.1% year over year, while operating profit fell 44.2% and profit attributable to the parent company dropped 54.7%. Its full-year guidance expects modest sales growth, lower profits, and an annual dividend of ¥47.
Confirmed
Global impact / market context
Sales growth alongside steep profit declines indicates that the company is keeping less profit from each yen of sales, though the supplied text does not explain why. If lower profits continue, earnings available to support investment or dividends could be constrained; the ¥47 dividend remains in guidance.
Analyst inference
The figures point to a gap between revenue and earnings: sales increased, but both operating and parent-attributable profit decreased. Because the full-year outlook also forecasts lower profits, investors may focus on whether sales growth can translate into stronger profit and whether the dividend guidance is maintained.
Analyst inference
What to watch
- Watch for the next reported sales and profit figures to see whether the 9M pattern persists; the supplied article gives no explanation for the profit decline. Analyst inference
- Compare later full-year guidance with the current forecast of modest sales growth and lower profits, noting whether management changes the outlook. Analyst inference
- Check whether the company maintains its ¥47 annual dividend in subsequent guidance or announcements; the supplied article reports this amount as current full-year guidance. Analyst inference
Evidence
- Original source link unavailable